Lipella Pharmaceuticals Common Stock Performance
| LIPO Stock | 0.19 0.05 20.83% |
The company secures a Beta (Market Risk) of 1.53, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lipella Pharmaceuticals will likely underperform. At this point, Lipella Pharmaceuticals has a negative expected return of -0.69%. Please make sure to verify Lipella Pharmaceuticals' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Lipella Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Lipella Pharmaceuticals Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Last Split Factor 1:8 | Last Split Date 2024-11-08 |
1 | Lipella Pharmaceuticals Announces Resignation of Board Member - TipRanks | 02/04/2026 |
Lipella Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 50.00 in Lipella Pharmaceuticals Common on November 17, 2025 and sell it today you would lose (31.00) from holding Lipella Pharmaceuticals Common or give up 62.0% of portfolio value over 90 days. Lipella Pharmaceuticals Common is currently does not generate positive expected returns and assumes 14.0012% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Lipella, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Lipella Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Lipella Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.19 | 90 days | 0.19 | about 78.81 |
Based on a normal probability distribution, the odds of Lipella Pharmaceuticals to move above the current price in 90 days from now is about 78.81 (This Lipella Pharmaceuticals Common probability density function shows the probability of Lipella Stock to fall within a particular range of prices over 90 days) .
Lipella Pharmaceuticals Price Density |
| Price |
Predictive Modules for Lipella Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lipella Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lipella Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lipella Pharmaceuticals is not an exception. The market had few large corrections towards the Lipella Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lipella Pharmaceuticals Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lipella Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.42 | |
β | Beta against Dow Jones | 1.53 | |
σ | Overall volatility | 0.10 | |
Ir | Information ratio | -0.03 |
Lipella Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lipella Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lipella Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lipella Pharmaceuticals generated a negative expected return over the last 90 days | |
| Lipella Pharmaceuticals has high historical volatility and very poor performance | |
| Lipella Pharmaceuticals has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 536.36 K. Net Loss for the year was (5.02 M) with loss before overhead, payroll, taxes, and interest of (3.42 M). | |
| Lipella Pharmaceuticals generates negative cash flow from operations | |
| Lipella Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Lipella Pharmaceuticals Announces Resignation of Board Member - TipRanks |
Lipella Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lipella Stock often depends not only on the future outlook of the current and potential Lipella Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipella Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 2.2 M |
Lipella Pharmaceuticals Fundamentals Growth
Lipella Stock prices reflect investors' perceptions of the future prospects and financial health of Lipella Pharmaceuticals, and Lipella Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lipella Stock performance.
| Return On Equity | -2.48 | ||||
| Return On Asset | -1.18 | ||||
| Operating Margin | (15.64) % | ||||
| Current Valuation | (704.49 K) | ||||
| Shares Outstanding | 4.62 M | ||||
| Price To Book | 0.60 X | ||||
| Price To Sales | 2.25 X | ||||
| Revenue | 536.36 K | ||||
| Gross Profit | (3.42 M) | ||||
| EBITDA | (5.01 M) | ||||
| Net Income | (5.02 M) | ||||
| Total Debt | 47.6 K | ||||
| Book Value Per Share | 0.61 X | ||||
| Cash Flow From Operations | (3.95 M) | ||||
| Earnings Per Share | (3.33) X | ||||
| Market Capitalization | 2.45 M | ||||
| Total Asset | 2.67 M | ||||
| Retained Earnings | (15.34 M) | ||||
| Working Capital | 1.86 M | ||||
About Lipella Pharmaceuticals Performance
By examining Lipella Pharmaceuticals' fundamental ratios, stakeholders can obtain critical insights into Lipella Pharmaceuticals' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Lipella Pharmaceuticals is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.16) | (2.05) | |
| Return On Capital Employed | (3.04) | (2.89) | |
| Return On Assets | (2.16) | (2.05) | |
| Return On Equity | (3.01) | (2.86) |
Things to note about Lipella Pharmaceuticals performance evaluation
Checking the ongoing alerts about Lipella Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lipella Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lipella Pharmaceuticals generated a negative expected return over the last 90 days | |
| Lipella Pharmaceuticals has high historical volatility and very poor performance | |
| Lipella Pharmaceuticals has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 536.36 K. Net Loss for the year was (5.02 M) with loss before overhead, payroll, taxes, and interest of (3.42 M). | |
| Lipella Pharmaceuticals generates negative cash flow from operations | |
| Lipella Pharmaceuticals has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Lipella Pharmaceuticals Announces Resignation of Board Member - TipRanks |
- Analyzing Lipella Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lipella Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Lipella Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lipella Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lipella Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lipella Pharmaceuticals' stock. These opinions can provide insight into Lipella Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipella Pharmaceuticals Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Will Biotechnology sector continue expanding? Could Lipella diversify its offerings? Factors like these will boost the valuation of Lipella Pharmaceuticals. Expected growth trajectory for Lipella significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lipella Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.33) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets | Return On Equity |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Lipella Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lipella Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Lipella Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.